Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2010, Vol. 8 ›› Issue (9): 819-823.doi: 10.3736/jcim20100903

• Review • Previous Articles     Next Articles

Guidelines for evidence-based Chinese medicine clinical pathway report

 Si-cheng Wanga,b,Jian-ping Liua, Hui Lic, He Yua,d   

  1. a Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China
    b Division of Science and Technology, Chinese State Administration of Traditional Chinese Medicine, Beijing 100026, China
    c Department of Acupuncture and Moxibustion, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou 510120, Guangdong Province, China
    d Department of Clinical Basic Medicine of Tradifional Chinese Medicine, School of Preclinical Medicine, Beijing University of Chinese Medicine, Beijing 100029, China
  • Received:2010-03-12 Accepted:2010-05-18 Online:2010-09-20 Published:2010-09-15

Clinical pathway (CP), as a standardized approach and clinical management process for disease diagnosing and treating, is being widely used with more relevant publications reported gradually. But different forms of CP reports may prevent the evaluation and spreading of CP. The authors recommend guidelines for evidence-based Chinese medicine CP report, including 18 items which form 5 big sections, by precise item selection and rigorous expert consensus. All these items can embody the principles of Chinese medicine and comply with the requirements of the clinical practice of Chinese medicine. All above are based on synthesizing the published literature systematically and analyzing the current status in this field, also according to the characteristics of Chinese medicine and methodology requirement of evidence-based medicine.

Key words: evidence-based medicine, Chinese medicine, clinical pathway, guidelines

"

条目 主题 注 释
1 标题 明确本路径报告的名称,是否中医临床路径,针对的主要临床疾病(或环节)
2 摘要 提供包括路径发表日期、版本及报告的结构性摘要,包括背景、目的、资料来源、制订过程等
3 制定者 明确制定组织的责任,提供制定小组的成员姓名、资质等信息
4 目标 介绍遵循路径预期可达到的目标,包括制定路径的总体指导思想和中医特点
5 适用范围 描述路径的适用范围,包括卫生保健服务提供者的类别及适用单位、机构条件资质等
6 目标病种/人群 明确路径适用的疾病病种(包括西医病种与中医病证)以及符合纳入路径标准的人群
7 中医干预 介绍中医药在该路径中的地位与作用,明确中医干预的环节与方法
8 证据收集 说明临床证据的来源与获取方法,如文献资料,应明确文献检索的时间、文献库范围、检索策略、筛选标准等
9 证据评价 描述证据的合成与评价方法,说明证据质量的评价标准,提供临床证据的分级推荐标准与推荐等级
10 预试结果 路径发布前制定者对该路径的评价、测试方法与结果
11 更新计划 表明路径的更新计划与周期
12 潜在的获益与风险 描述执行路径的预期获益和潜在的风险
13 路径标准操作流程 注明路径的适用对象、诊断依据、治疗方案的选择、诊疗方案、标准住院日、进入路径标准、检查项目、出院标准、变异及原因分析等内容,并可根据路径描述的实施步骤与决策绘制路径实施流程图
14 医师版临床路径表 以时间为横轴、诊疗项目为纵轴的表格,将临床路径确定的诊疗任务依时间顺序以表格清单的形式罗列出来
15 患者版临床路径告知单 用于向患者告知其需要接受的诊疗服务过程的表单。以通俗易懂的语言向患者介绍具体的治疗过程
16 变异记录单 记录和分析临床路径实施过程中的变异情况,记录的内容将作为分析路径实施效果的重要参考依据
17 临床诊疗规范化文件 包括临床诊疗标准操作规程,疾病诊断、中医辨证标准,疗效评价标准,治疗方案和操作标准等
18 管理文件 包括法律法规、医院规章制度和职责类文件、医院管理和评价指南类文件等
[1] Graybeal KB, Gheen M, McKenna B .Clinical pathway development: the Overlake Model[J]. Nurs Manage, 1993,24(4):42-45
pmid: 8474749
[2] Coffey RJ, Richards JS, Remmert CS, LeRoy SS, Schoville RR, Baldwin PJ .An introduction to critical paths[J]. Qual Manag Health Care, 1992,1(1):45-54
[3] Zhang HY, Dong J . Application of clinical pathways on hospital management[J]. Guo Wai Yi Xue Yi Yuan Guan Li Feng Ce, 2001,18(3):98-101
张宏雁, 董军 . 临床途径在医院管理中的应用[J]. 国外医学:医院管理分册, 2001,18(3):98-101
[4] Zander K .Integrated care pathways: eleven international trends[J].J Integr Care Path, 2002, 6: 101-107
doi: 10.1177/147322970200600302
[5] Hindle D, Yazbeck AM . Clinical pathways in 17 European Union countries: a purposive survey[J]. Aust Health Rev, 2005,29(1):94-104
doi: 10.1071/ah050094 pmid: 15683361
[6] Vanhaecht K, Bollmann M, Bower K, Gallagher C, Gardini A, Guezo J, Jansen U, Massoud R, Moody K, Sermeus W, Zelm RV, Whittle C, Yazbeck AM, Zander K, Panella M .Prevalence and use of clinical pathways in 23 countries: an international survey by the European Pathway Association[J].J Integr Care Path, 2006, 10: 28-34
[7] Vanhaecht K, De Witte K, Depreitere R, Van Zelm R, De Bleser L, Proost K, Sermeus W . Development and validation of a care process self-evaluation tool[J]. Health Serv Manage Res, 2007,20(3):189-202
doi: 10.1258/095148407781395964 pmid: 17683658
[8] Hedman P, Palmer JS . A critical pathway for successful outpatient ureteral reimplantation: a nursing perspective[J]. J Perianesth Nurs, 2009,24(3):163-166
doi: 10.1016/j.jopan.2009.03.009 pmid: 19500749
[9] Kinsman L, James E, Ham J . An interdisciplinary, evidence-based process of clinical pathway implementation increases pathway usage[J]. Lippincotts Case Manag, 2004,9(4):184-196
doi: 10.1097/00129234-200407000-00006
[10] De Bleser L, Depreitere R, De Waele K, Vanhaecht K, Vlayen J, Sermeus W . Defining pathways[J]. J Nurs Manag, 2006,14(7):553-563
doi: 10.1111/jnm.2006.14.issue-7
[11] Kang Y, Zhang ZY . Basic problem of clinical pathways implementation: quality and application of clinical path chart[J]. Zhongguo Wei Sheng Zhi Liang Guan Li, 2005,12(4):23-24
doi: 10.3969/j.issn.1006-7515.2005.04.010
康颖, 张志英 . 实施临床路径基础问题——临床路径图质量与应用[J]. 中国卫生质量管理, 2005,12(4):23-24
doi: 10.3969/j.issn.1006-7515.2005.04.010
[12] Zhou BL, Ying LP. Application guide for clinical pathways[M]. Beijing: Peking University Medical Press,2007: 22-23
周保利, 英立平 . 临床路径应用指南[M]. 北京: 北京大学医学出版社,2007: 22-23
[13] Cui SQ, Liang WN. The clinical guideline application manual[M]. Beijing: People’s Medical Publishing House,2003: 112-113
崔树起, 梁万年 . 临床指南实用手册[M]. 北京: 人民卫生出版社,2003: 112-113
[14] Ministry of Health of the People’s Republic of China. Management guiding principle of clinical pathways (trial implementation).[ 2010-02-18].
中华人民共和国卫生部. 临床路径管理指导原则(试行).[ 2010-02-18].
[15] Wang SC, Han M, Liu JP . Summary of clinical pathways and clinical application in traditional Chinese medicine[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2009,29(12):1067-1069
王思成, 韩梅, 刘建平 . 临床路径概要及中医临床应用思路[J]. 中国中西医结合杂志, 2009,29(12):1067-1069
[16] Liu JP . Body composition of traditional medical evidence and evidence grading of recommendations[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2007,27(12):1061-1063
doi: 10.3321/j.issn:1003-5370.2007.12.001
刘建平 . 传统医学证据体的构成及证据分级的建议[J]. 中国中西医结合杂志, 2007,27(12):1061-1063
doi: 10.3321/j.issn:1003-5370.2007.12.001
[17] Kan QC . The application of PDCA cycle in hospitals strategic management[J]. Zhongguo Yi Yuan Guan Li, 2009,29(8):47-49
doi: 10.3969/j.issn.1001-5329.2009.08.021
阚全程 . PDCA循环在医院战略管理中的运用[J]. 中国医院管理, 2009,29(8):47-49
doi: 10.3969/j.issn.1001-5329.2009.08.021
[18] Gray M, Tang JL. Evidence-based medicine: evidence-based health care decision-making[M]. Beijing: Peking University Medical Press,2004: 21-31
Gray M, 唐金陵. 循证医学:循证医疗卫生决策[M]. 北京: 北京大学医学出版社,2004: 21-31
[1] Sherman Gu, Arthur Yin Fan. Controversial conclusions from two randomized controlled trials for acupuncture's effects on polycystic ovary syndrome or in vitro fertilization support. Journal of Integrative Medicine, 2020, 18(2): 89-91.
[2] Xue-qing Yu, Shu-guang Yang, Yang Xie, Jian-sheng Li. Traditional Chinese medicine in the treatment of idiopathic pulmonary fibrosis based on syndrome differentiation: Study protocol of exploratory trial. Journal of Integrative Medicine, 2020, 18(2): 163-168.
[3] Chang-quan Ling. Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2). Journal of Integrative Medicine, 2020, 18(2): 87-88.
[4] Wen Qiang Lee, Jeremy Teoh, Pei Zheng Kenneth Lee, Zhi Xiong Gerard Low, Xueling Sim, Foong Fong Mary Chong, Norbert Ludwig Wagner. Factors influencing communication of traditional Chinese medicine use between patients and doctors: a multisite cross-sectional study. Journal of Integrative Medicine, 2019, 17(6): 396-403.
[5] Charles Dalcanale Tesser, Ari Ojeda Ocampo Moré, Melissa Costa Santos, Emiliana Domingues Cunha da Silva, Fátima Terezinha Pelachini Farias, Lúcio José Botelho. Auriculotherapy in primary health care: A large-scale educational experience in Brazil. Journal of Integrative Medicine, 2019, 17(4): 302-309.
[6] Mikhail Teppone. Medicine has always been “Modern” and “Scientific” from ancient times to the present day. Journal of Integrative Medicine, 2019, 17(4): 229-237.
[7] Rachael Farrington, Ian F.Musgrave, Roger W.Byard. Evidence for the efficacy and safety of herbal weight loss preparations. Journal of Integrative Medicine, 2019, 17(2): 87-92.
[8] Fung-Kei Cheng. An overview of the contribution of acupuncture to thyroid disorders. Journal of Integrative Medicine, 2018, 16(6): 375-383.
[9] Chang-quan Ling, Jia Fan, Hong-sheng Lin, Feng Shen, Zhen-ye Xu, Li-zhu Lin, Shu-kui Qin, Wei-ping Zhou, Xiao-feng Zhai, Bai Li, Qing-hui Zhou, on behalf of the Chinese Integrative Therapy of Primary Liver Cancer Working Group. Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine. Journal of Integrative Medicine, 2018, 16(4): 236-248.
[10] Ioannis Solos, Yuan Liang. A historical evaluation of Chinese tongue diagnosis in the treatment of septicemic plague in the pre-antibiotic era, and as a new direction for revolutionary clinical research applications. Journal of Integrative Medicine, 2018, 16(3): 141-146.
[11] Wan-fu Lin, Jian-ying Lu, Bin-bin Cheng, Chang-quan Ling. Progress in research on the effects of traditional Chinese medicine on the tumor microenvironment. Journal of Integrative Medicine, 2017, 15(4): 282-287.
[12] Zheng Gan, Ge-liang Yang, Yi-fu Fan, Hong-yun Chen, Wei Gu, Chang-quan Ling. China's growing contribution to military Chinese medicine (2005-2014): A ten-year literature survey. Journal of Integrative Medicine, 2016, 14(6): 480-484.
[13] Arthur YinFan. The legendary life of Dr. Gim Shek Ju, the founding father of the education of acupuncture and Chinese medicine in the United States. Journal of Integrative Medicine, 2016, 14(3): 159-164.
[14] Qing Ji, Yun-quan Luo, Wen-hai Wang, Xuan Liu, Qi Li, Shi-bing Su. Research advances in traditional Chinese medicine syndromes in cancer patients. Journal of Integrative Medicine, 2016, 14(1): 12-21.
[15] Mojtaba Heydari, Mohammad Hashem Hashempur, Mohammad Hosein Ayati, Detlev Quintern, Majid Nimrouzi, Seyed Hamdollah Mosavat. The use of Chinese herbal drugs in Islamic medicine. Journal of Integrative Medicine, 2015, 13(6): 363-367.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[2] . Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication (Chinese version, part two). Journal of Chinese Integrative Medicine, 2010, 8(11): 1001-1005
[3] Ming-qing Wei , Jin-zhou Tian , Jing Shi , Fu-yun Ma , Ying-chun Miao , Yong-yan Wang. Effects of Chinese medicine for promoting blood circulation and removing blood stasis in treating patients with mild to moderate vascular dementia: a randomized, double-blind and parallel-controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(11): 1240-1246
[4] Rui Guo, Yi-qin Wang, Jian-jun Yan, Han-xia Yan, Yu-ci Yang. Study of traditional Chinese medicine pulse signals in patients with coronary heart disease based on recurrence quantification analysis. Journal of Chinese Integrative Medicine, 2011, 9(11): 1226-1233
[5] Mei-jun Lü, Hui-yong Zhang, Zhe Zhang, Guan-lin Yang. Measurement of health-related quality of life in coronary heart disease: A review. Journal of Chinese Integrative Medicine, 2011, 9(12): 1277-1285
[6] Li Dong-tao, Li Fu-yu, Wang Jian, Liu Ji-hong, Yan Nan, Cheng Yong-mei, Hu Ai-hua, Jiang Hong-yang, Shi Feng-lei, Zhang Mei-zeng, Li Jie, Wei Ling-bo, Jiang Rong-qin. A study of diagnostic criteria for traditional Chinese medicine syndromes in osteoporosis. Journal of Chinese Integrative Medicine, 2011, 9(12): 1326-1332
[7] Zhi-rong Zhu, Chang-chun Zeng, Li Yang, Han-ping Liu, Song-hao Liu. Influence of brightness value of supranasal point and apex nasi on dominant wavelength and excitation purity in complexion inspection of healthy adults. Journal of Chinese Integrative Medicine, 2011, 9(12): 1333-1338
[8] Mu-yun Zhu, Zheng-hua Jiang, Yuan-wen Lu, Yuan Guo, Jun-ji Gan. Matrine and anti-tumor drugs in inhibiting the growth of human lung cancer cell line. Journal of Chinese Integrative Medicine, 2008, 6(2): 163-165
[9] Li-hui Dang, Xiao-nan Yang, Qing Xia. Protective effects of Chaiqin Chengqi Decoction on isolated pancreatic acinar cells in acute pancreatitis rats and the mechanisms. Journal of Chinese Integrative Medicine, 2008, 6(2): 176-179
[10] Le Kuai, Hao Chen, Hua-yuan Yang. Current status and prospect of acupuncture-moxibustion in treatment of cancer pain: a review. Journal of Chinese Integrative Medicine, 2008, 6(2): 197-201